Bioventus Inc.
06/04/2026 | Press release | Distributed by Public on 06/04/2026 05:54
Proxy Results (Form 8-K)
Item 5.07. Submission of Matters to a Vote of Security Holders.
Bioventus, Inc. (the "Company") held its 2026 Annual Meeting of Stockholders (the "2026 Annual Meeting") on June 3, 2026. A total of 75,279,174 shares (the "Shares") of both Class A common stock and Class B common stock (collectively, the "Common Stock") were present in person or represented by proxy at the 2026 Annual Meeting, representing approximately 90.23% of the outstanding Shares of Common Stock entitled to vote as a single class as of the April 6, 2026 record date.
The following proposals were voted upon at the 2026 Annual Meeting and the final voting results with respect to each such proposal are set forth below.
At the 2026 Annual Meeting, the stockholders elected the following directors to serve on the Company's Board of Directors until the 2027 annual meeting of stockholders and until each such director's respective successor is elected and qualified, or until each such director's death, resignation or removal, based on the following votes:
|
Nominee
|
For
|
Withheld
|
Broker Non-Votes
|
|||||||||||||||||
|
William A. Hawkins
|
67,405,961
|
1,128,994
|
6,744,219
|
|||||||||||||||||
|
John A. Bartholdson
|
68,365,980
|
168,975
|
6,744,219
|
|||||||||||||||||
|
Patrick J. Beyer
|
68,062,114
|
472,841
|
6,744,219
|
|||||||||||||||||
|
Robert E. Claypoole
|
68,360,467
|
174,488
|
6,744,219
|
|||||||||||||||||
|
Philip G. Cowdy
|
67,748,512
|
786,443
|
6,744,219
|
|||||||||||||||||
|
Ajay Dhankhar
|
68,459,149
|
75,806
|
6,744,219
|
|||||||||||||||||
|
Mary Kay Ladone
|
67,160,936
|
1,374,019
|
6,744,219
|
|||||||||||||||||
|
Michelle McMurry-Heath
|
68,073,685
|
461,270
|
6,744,219
|
|||||||||||||||||
|
Guido J. Neels
|
68,049,659
|
485,296
|
6,744,219
|
|||||||||||||||||
|
Guy P. Nohra
|
67,767,651
|
767,304
|
6,744,219
|
|||||||||||||||||
|
Susan M. Stalnecker
|
68,060,987
|
473,968
|
6,744,219
|
|||||||||||||||||
|
Martin P. Sutter
|
61,710,650
|
6,824,305
|
6,744,219
|
|||||||||||||||||
The stockholders also ratified the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The vote for such ratification was 75,228,481 Shares for, 5,021 Shares against, 45,672 Shares abstaining, and no broker non-votes.
Bioventus Inc. published this content on June 04, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 04, 2026 at 11:54 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]